United States
US 12,697,388 B2
Chimeric antigen receptors targeting CD127 and use thereof
US 12,697,388 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: Ose Immunotherapeutics; Memorial Sloan-Kettering Cancer Center. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Ose Immunotherapeutics; Memorial Sloan-Kettering Cancer Center
- Inventors
- Prasad S. Adusumilli; Nicolas Poirier
- Publication date
- 2026-08-04
- Filing date
- 2022-10-26
- Document type
- B2 Granted patent
- Also written as
- US 12,697,388 B2 · US12697388 · 12697388
Abstract
The presently disclosed subject matter provides methods for treating neoplasia using cells comprising an antigen-recognizing receptor (e.g., a chimeric antigen receptor (CAR)) that specifically targets CD127.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free